This gene panel eliminates the need for invasive tissue biopsies by utilizing peripheral blood samples. It allows for more accessible sample collection and enables tumor biology monitoring without invasive procedures.

This gene panel provides oncologists with clinically actionable insights from individual patients’ peripheral blood. The detailed genetic information obtained through this gene panel testing allows oncologists to make informed treatment decisions.

This gene panel includes common and rare gene fusions and identifies novel fusion partners. This aspect of the gene panel testing is particularly valuable as it expands the understanding of fusion events in cancer, potentially uncovering new therapeutic targets or diagnostic markers that were previously unknown.

This gene panel goes beyond genetic alterations by incorporating microsatellite instability (MSI), which is crucial in predicting response to immune checkpoint inhibitors. The immunotherapy treatment based on MSI status has shown remarkable success in certain cancer affected patients.

Our Cancer Gene Panel thoroughly assesses clinically relevant genes, ensuring accurate and reliable results.

We utilize cutting-edge next generation sequencing technology to deliver precise and detailed genetic information.

Our team of experienced genetic counselors and healthcare professionals will guide you through the testing process, answer your questions, and help you understand the implications of the results.

We adhere to strict privacy protocols and maintain the confidentiality of your genetic information.